Combination Zibotentan/Dapagliflozin Reduces Albuminuria in CKD
Results of the ZENITH-CKD trial provide evidence of the safety and efficacy profile of combination zibotentan plus dapagliflozin in patients with chronic kidney disease.
Source: hcplive.com